pCCLCHIM-p47 (Lentiviral Vector Transduced CD34+ Cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pCCLCHIM-p47 (Lentiviral Vector Transduced CD34+ Cells), covering 2026-02-23 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD) [Phase 1, Phase 2]